Future studies are necessary to ascertain the tissue origin of the steatogenic effect of Smurf1 ablation using conditional knockout approaches and to determine if and how BL-Smurf1 mice could be enticed to progress through NASH or even liver cancer to model the entire NAFLD disease spectrum. The gene discussed is SMURF1; the disease is metabolic dysfunction-associated steatotic liver disease.